#AI Stock News: VSBLTY (CSE: $VSBY.C) CEO REPORTS ON COMPANY IMPLEMENTATION OF AI AND MACHINE LEARNING TECHNOLOGY

#AI Stock News: VSBLTY (CSE: $VSBY.C) CEO REPORTS ON COMPANY IMPLEMENTATION OF AI AND MACHINE LEARNING TECHNOLOGY

PHILADELPHIA, PA., June 13, 2019 (Investorideas.com Newswire) Jay Hutton, co-founder & CEO of VSBLTY Groupe Technologies Corp. (CSE: VSBY) (5VS.F) (VSBGF), a leading retail software and technology company, today reported on the recent progress of the company in selling its artificial intelligence and machine learning technology.

Read this in full at https://www.investorideas.com/CO/VSBY/news/2019/06131CEOReports-AI-MachineLearning.asp

“We have been working hard to lead the way in deploying our software in various activations that are monumental in the effect they have on driving innovation in both the retail and security worlds,” Hutton said.

Strategically, VSBLTY’s efforts have been focused on force multipliers. “The channel partners we have selected,” Hutton stated,” are dominant players in each of their selected categories. Our alignment with these companies brings to them world class software, expertise and scalable solutions. In return, VSBLTY gets a rapid deployment capability and an acceleration capacity that we could never achieve ourselves,” he explained.

“We have been fortunate to join forces with many of the largest, most influential mass integrators of their class,” Hutton said. He offered some highlights of what VSBLTY teams are working to accomplish to maintain its leadership position and help its clients drive innovation and ROI.

Key Commercial Contracts

VSBLTY has signed its first large deployment using vending machines in South Africa, which is slated to begin generating revenue by July. This business, referred by Intel (NYSE: INTC), replaces the Intel AIM software suite that previously provided data derived from computer vision, which has been discontinued.

VSBLTY technology has been deployed—and producing revenue—in conjunction with a large, world-class, integrated, point of purchase (POP) display manufacturer that works on behalf of many Fortune 50 consumer package goods (CPG) companies. The first deployment is with a large drug retailer and highlights a unique, interactive digital experience. VSBLTY’s ability to collaborate with a major display manufacturer on design and implementation options has accelerated their bringing innovative solutions to CPG clients directly.

The company is in the final stages of signing a partnership agreement with the largest in-store media sales company in the U.S and Canada. This relationship provides speed to market in which VSBLTY solutions can be sold as a media network purchase.

VSBLTY is on the fast track to complete an OEM and global supply and cooperation agreement with one of the world’s most prominent international retail services companies.

CIC Technologies

The company’s current development efforts with CIC Technologies (http://www.getcictech.com), a full-service technology company specializing in security solutions, represents a strategic product extension. VSBLTY and CIC Technologies are co-developing a cost-effective multifactor authentication system for employee validation with facial recognition.

Latin American Smart City

VSBLTY is in the final testing stages to provide crowd analytics and facial recognition on a massive scale in a key Latin American country.

Smart Buildings

Hutton says another new, exciting partner manages smart buildings throughout the world. VSBLTY is joining forces with the firm to create the latest software application for enhanced security using its proprietary AI and machine learning technology. The company is also providing a more engaging way to communicate important information to guests and tenants.

Product Evolution

The VSBLTY tech team is working on the next generation design of an in-store grocery bunker cooler on behalf of one of the world’s largest international food companies. The firm is adding digital display innovation in time for the barbeque season that features hot dogs and cross promotes complimentary condiments.

Conference Exhibit Partnerships

VSBLTY is participating in Cisco Live (NASDAQ: CSCO) the week of June 9 in San Diego where they will be demonstrating the VSBLTY Vector™ software in a weapons detection use case. And, during the last week of May, at the Sweets & Snacks Expo, in Chicago, VSBLTY was part of the Lighting for Impact (https://www.lightingforimpact.com/) exhibit featuring Mars candy. Lighting for Impact is one of America’s leading providers of LED lighting and power systems for retailers.

Summarizing, Hutton said, “All of us at VSBLTY continue to be excited about our vast potential and energized by the market’s reaction to the exciting new innovations that our software technology is bringing to both retail and security.” 

Investor Relations

MarketSmart Communications Inc.

+1-877-261-4466

info@marketsmart.ca

CONTACT: Linda Rosanio, 609-472-0877lrosanio@vsblty.net

About VSBLTY (www.vsblty.net) 

Headquartered in Philadelphia, VSBLTY (CSE: VSBY) (Frankfurt: 5VS) (OTC: VSBGF) is the world leader in Proactive Digital Display™, which transforms retail and public spaces as well as place-based media networks with SaaS-based audience measurement and security software that uses artificial intelligence and machine learning.  

VSBLTY Groupe Technologies Corp. (CSE: VSBY) is a featured Tech / AI stock on Investorideas.com

Visit profile page

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: VSBLTY is a paid PR, news and social media client on Investorideas.com as of March 1, 2019  https://www.investorideas.com/About/Disclaimer.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (CSE: $INDS.C) (TSX: $TGOD.TO) (TSXV: $NRTH.V)

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (CSE: $INDS.C) (TSX: $TGOD.TO) (TSXV: $NRTH.V)

Delta, Kelowna, BC –June 12, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcasts^CM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/061219-StocksToWatch.mp3

Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/06121INDS-TGOD-NRTH.asp

Hear Investor ideas cannabis potcast on iTunes  

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we are looking at a few early announcements.

But first, Trait Biosciences Inc., North America's leading research laboratory in hemp and cannabis innovations, today announced that it has completed the first-ever successful stable genetic transformation of the Cannabis sativa (hemp) plant.

The achievement was completed by Trait's team of more than 40 scientists and researchers, led by Dr. Richard Sayre, from its licensed facility in Los Alamos, New Mexico. While efforts have been made by other researchers and companies to metabolically engineer the Cannabis sativa plant, Trait's achievement is believed to represent the first time a hemp plant has been stably transformed and successfully grown roots and stems.

This scientific achievement paves the way for Trait Biosciences to begin its efforts to commercialize its Trait Amplified™, Zero™ and Tailored™ technologies.

"Successful transformation of the hemp plant is a pivotal milestone for our company," said Dr. Sayre, Chief Science Officer of Trait. "For us, it is the foundation on which we will be able to develop strains of hemp and cannabis with novel traits, including our Trait Amplified™ technology. Plants grown with Amplified are expected to have more trichomes, have greater photosynthetic efficiency and are expected to generate cannabinoid yields 2x – 5x higher than conventional plants for whole plant extracts, in addition to being able to produce water-soluble cannabinoids, which have far greater bioavailability and onset time than fat-soluble cannabinoids."

The successful transformation was confirmed by polymerase chain reaction and gene sequencing of the gene of interest, with the frequency of the transformation event being 6.7%.

Peter McDonough, Chief Executive Officer of Trait Biosciences, added "This is a major development for Trait and for all who use hemp and cannabis products. For patients who rely on cannabinoid therapies to improve their health, as well as those adult-use customers who use hemp and cannabis for recreational purposes, this means they will soon have access to products that will be more affordable, have better quality and deliver more predictable, repeatable experiences than anything that is on the market currently."

Indus Holdings, Inc. (CSE:INDS) today announced that it has acquired 70% of the issued and outstanding shares of Shredibles LLC in exchange for subordinate voting shares of Indus Holdings, Inc. The total transaction is valued at $240,000, based on the closing price of the Company's subordinate voting shares on June 11, 2019.

Shredibles, one of the first protein bars to infuse CBD oil with all-natural, vegan-friendly ingredients, are a handmade, healthy, post-workout alternative. Individual bars are infused with 20mg of CBD and are available in White Chocolate Macadamia, Peanut Butter Crunch, and Dark Chocolate Blueberry Almond flavors.

Shredibles bars are popular beyond the traditional CBD-based retail market and are currently available in select gyms, yoga studios, grocery, and health stores. Additionally, several notable athletes and artists have begun partnering with Shredibles through sponsorship and brand ambassador relationships.

"Our goal has long been to create a healthy recovery snack that pushes the boundaries of what's possible with CBD," explains Co-Founder and Chief Executive Officer Roddy Hanson. "We felt an instant synergy after our first meeting with the Indus team, and the partnership will allow us to realize our vision for Shredibles," adds Matt Callans, co-founder and chief operating officer. 

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) announced that it has entered into a multi-year agreement with Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) for extraction, formulation and packaging services. As part of the agreement, TGOD will have exclusivity on extraction, formulation and packaging of certified organic products within and for the Canadian market. Neptune's expertise will enable TGOD to quickly scale up production of a wide range of consumer wellness products.

Under the terms of the agreement, TGOD will allocate more than 230,000 kilograms of cannabis and hemp biomass for Neptune to process and transform into premium certified organic consumer wellness products, making this the largest deal for a processor in the industry to date.

The contract between TGOD and Neptune covers a period of three years and is expected to be back-end loaded with the first year accounting for approximately 20% of the total value. It also marks a significant milestone for cannabis manufacturing in Quebec, creating high value jobs, complementing TGOD's large investment in Valleyfield where the Company is nearing the completion of the first phase of what will become the world's largest organic cannabis growing facility at over 1.3 million square feet.

"With this agreement, Neptune becomes a key partner for TGOD; we have been impressed with their commitment to innovation and excellence in every aspect of their business. Their unique capabilities in terms of extraction, formulation and packaging were decisive factors in our selection process," commented Brian Athaide, CEO of TGOD. "Today's announcement is significant not only because it enables us to start manufacturing certified organic consumer wellness products at scale, but also because of the large and sustained economic impact it will have in Quebec where TGOD is building the world's largest organic cannabis production facility."

TGOD will work closely with Neptune's team to assist them in obtaining their organic certification. To facilitate the certification process, Neptune will allocate a dedicated space to house and operate TGOD's proprietary and/or licenced technologies. In addition, Neptune is in the process of achieving the EU-GMP certification, allowing TGOD to export products to other jurisdictions as laws and regulations permit.

48North Cannabis Corp. (TSXV:NRTH) recently announced that it has signed a supply agreement with the Ontario Cannabis Store ("OCS"), Ontario's sole wholesaler and online retailer for recreational cannabis.

Under the supply agreement, 48North will supply the OCS with 1,200 kilograms of dried cannabis from its outdoor farm in Brant County, Ont., ("Good Farm") and other cannabis products such as pre-rolls from its indoor facilities in Brantford, Ont., ("Good House") and Kirkland Lake, Ont.

48North's Good Farm is expected to produce an estimated 40,000 kilograms of organic, sun-grown cannabis from more than 3.7 million square feet of outdoor cultivation space. At Good Farm, 48North expects to harvest cannabis at what is expected to be one of the lowest cost per gram in the country.

This supply agreement marks the Company's third outdoor supply agreement with a provincial wholesaler for outdoor-grown cannabis. Previously, 48North signed agreements with the Société québécoise du cannabis (SQDC) for 1,200 kilograms of dried cannabis, and Alberta Gaming, Liquor & Cannabis (AGLC) for 2,460 kilograms of dried cannabis. To that end, 48North has committed nearly 5,000 kilograms of dried cannabis from its Good Farm in 2019 to the Canadian recreational cannabis flower market.

"48North is looking forward to delivering high-quality, sun-grown, low-cost and organic cannabis to some of the largest cannabis markets in the country. Through a series of historic supply agreements, 48North has solidified its place as part of the solution in addressing the significant supply shortages facing the Canadian recreational cannabis market," said Alison Gordon, co-CEO of 48North.

48North Cannabis Corp. also announced that it has shipped its first order of cannabis to the Société québécoise du cannabis (SQDC) for retail sale. The shipment marks the Company's first foray into the Canadian recreational retail market.

In February, the Company announced that it had signed Canada's first-ever letter of intent for outdoor- grown cannabis with the SQDC, Quebec's sole legal retailer of recreational cannabis. Under the agreement, 48North agreed to supply 1,200 kilograms of cannabis to the SQDC from its outdoor farm in Brant County, Ont., and 120 kilograms of indoor-grown cannabis from its facilities in Brantford, Ont., and Kirkland Lake, Ont. Today's shipment pertains to the 120 kilograms from its indoor facilities.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the

Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas podcasts    

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411

  Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories

#Pharma & #Cannabis Stocks See Opportunities in Europe: (OTCQB: $INNV) (ASX: OCC) (NASDAQ: $PCRX) (TSXV: $HVT.V) (OTCQX: $HRVOF)

#Pharma & #Cannabis Stocks See Opportunities in Europe: (OTCQB: $INNV) (ASX: OCC) (NASDAQ: $PCRX) (TSXV: $HVT.V) (OTCQX: $HRVOF)

Muscle and Repair Treatments versus Surgery and how Europe and Global Markets offer New Opportunities

Point Roberts, WA and Delta, BC - June 12, 2019 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering biotechnology and pharmaceutical stocks releases a sector snapshot reporting on the ongoing growth of OTC pain medication due to consumer demand and a move away from traditional surgeries. More companies are taking a global approach and are seeking to gain approval not only in the US, but also European markets moving forward.

According to a market research report published by P&S Intelligence, the chronic pain treatment market is “expected to reach $105.9 billion by 2024. The market growth is primarily driven by the rising prevalence of chronic conditions, surging geriatric population, and increasing government support toward chronic pain management.”

MotleyFool recently discussed the key differences between the United States and European drug markets, specifically focusing on the key differences in drug approval. “The United States and Europe are drugmakers' biggest markets, but just because a drug wins approval in one doesn't mean it will get the nod in the other. Each market has its own system for clinical trials and drug reviews, and there are key differences in commercializing drugs in these regions that investors ought to know about before investing.”

Looking to European markets, Innovus Pharmaceuticals, Inc. (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women's health and respiratory diseases, recently announced that it has received the CPNP notification number required to commercialize CarvaNum®, its product for muscle recovery, in all 28 member countries of the European Union. This represents the fifth Innovus Pharma product to receive CPNP notification in the European Union so far, the others being Zestra®, Zestra Glide®, Sensum+®, and Diabasens®. The product will be available as an over the counter (“OTC”) or behind the counter product and does not require a prescription.

Read this in full at https://www.investorideas.com/news/2019/biotech/06121PharmaCannabis-Europe.asp

“We are pleased to announce the receipt of the CPNP in the European Union for CarvaNum®. CarvaNum®’s market for muscle recovery is fairly large in the EU and we look forward to growing it along with our other products in that region,” said Innovus Pharma CEO, Dr. Bassam Damaj.

“We will continue to file for approval for other products in the European Union, as we expect to grow our approved and/or notified product portfolio there in 2019 to also include Vesele®, UriVarx®, Prostagorx®, ArthriVarx®, Trexar® and BH Testosterone®.”

Innovus is also working on filing for CarvaNum® as a homeopathic drug for muscle cramps in the US and Canada.

Orthocell Limited (ASX: OCC) recently provided its first batch of evidence supporting the efficacy of its CelGro™ nerve regeneration platform.

The company published results on the first four patients to complete the clinical trial using CelGro™, with patients experiencing an 83% improvement in muscle power.

Orthocell said it conducted the trial to demonstrate the effectiveness of CelGro™ and confirm that the platform can be used to guide and promote “tensionless nerve regeneration in damaged peripheral nerves of the hand and upper limb.”

If successfully proven, Orthocell plans to market its CelGro™ platform in Europe and other major markets globally. In the US alone, over 20 million people suffer from peripheral nerve injury as a result of acute muscle injuries every year, at an annual cost of approximately US$150 billion (A$213 billion).

Pacira BioSciences, Inc. (NASDAQ: PCRX) recently announced the publication of its multinational Phase 3 study supporting the efficacy and safety of EXPAREL® (bupivacaine liposome injectable suspension) as a single-injection interscalene brachial plexus nerve block (ISNB) in patients undergoing total shoulder arthroplasty or rotator cuff repair. The results demonstrate that EXPAREL® significantly improved pain control and reduced opioid consumption through 48 hours compared with placebo and a standardized pain management protocol alone. The data, which provided the basis for FDA approval for this indication, was published in Pain Medicine.

“Traditionally, clinicians seeking regional pain control have been forced to choose between single-injection blocks with a duration of efficacy that does not match analgesic requirements or continuous blocks that are long-lasting but hinder patient mobility due to cumbersome catheters and pumps. Results from this study illustrate the clinical effectiveness of interscalene brachial plexus nerve block with EXPAREL®, which provides prolonged pain control in a single dose without the need for additional equipment,” said Manish Patel, orthopedic surgeon at Eastern Virginia Medical School in Franklin, VA who was also a study investigator and is lead author on the publication. “Further, robust pain control coupled with a reduction or total elimination of opioid requirements, as EXPAREL® demonstrated in this study, are two critical factors toward the increasing clinical goal of moving inpatient procedures to an outpatient setting.”

This uptrend in pain management treatment is also attracting outside interest from the Cannabis sector as Harvest One Cannabis Inc (TSXV;HVT) (OTCQX:HRVOF) recently announced that it has entered into a definitive agreement to acquire Delivra Corp. for C$19 million, in a stock deal to strengthen its medical and wellness division.

Harvest One's acquisition of Delivra furthers the company's health, wellness, and self-care strategy by adding LivRelief™ to its medical and wellness portfolio. Delivra’s LivRelief™ brand produces a variety of topicals and creams with existing distribution channels across Canada. This will well position Harvest One for the time when cannabis-infused products are legalized in Canada, around Fall of 2019.

"The acquisition of Delivra by Harvest One puts further emphasis on the Harvest One goal of being a leading house of brands in the global health, wellness, and self-care sector,” said Harvest One CEO, Grant Froese. “The addition of LivRelief™, which is already on retail shelves across Canada, will give Harvest One a head start for cannabis-infused products in Canada.”

Though many tend to look at the US as the largest market in dollar terms, the European market is still significant with more than 741 million people living there, a fact many of these OTC pain medication companies are taking into consideration when looking to maximize exposure and company revenues moving forward. OTC pain medication is showing impressive gains, but this is a global market moving forward and the companies who gain approval in both markets are hoping to gain a competitive advantage.

Visit the Investorideas.com biotech and pharma stock directory at Investorideas.com

https://www.investorideas.com/membership/

About Investorideas.com - News that Inspires Big Investing Ideas

https://www.investorideas.com/About/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: this  article featuring INNV is a paid for service on Investorideas.com ( two thousand ) by a third party. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Contact Investorideas.com

800-665-0411

 Get more Biotech Investor Ideas – news, articles and stock directories 

The #AIEye: AWS Makes Amazon (NasdaqGS: $AMZN) Personalize Generally Available and Baidu (NYSE: $BIDU) Reveals Extent of Partnerships for DuerOS Apollo IoV Platform

The #AIEye: AWS Makes Amazon (NasdaqGS: $AMZN) Personalize Generally Available and Baidu (NYSE: $BIDU) Reveals Extent of Partnerships for DuerOS Apollo IoV Platform

Machine Learning in Middle East and Africa 2018-2023 to See 29.1% CAGR

Point Roberts WA, Vancouver BC – June 11, 2019  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2019/061119-AI-Eye.mp3

Read this in full at

https://www.investorideas.com/news/2019/artificial-intelligence/06111AIEye-AMZN-BIDU.asp

Hear the Ai Eye on Spotify  

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:AMZN) (NYSE:BIDU)

Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN), has announced the general availability of its Amazon Personalize solution. Personalize allows users to leverage machine learning technology to “develop applications with a wide array of personalization use cases, including specific product recommendations, individualized search results, and customized direct marketing”. Swami Sivasubramanian, Vice President of Machine Learning, Amazon Web Services, Inc., commented:

“We are excited to share with AWS customers the expertise we’ve developed during two decades of using machine learning to deliver great experiences on Amazon.com. Customers have been asking for Amazon Personalize, and we are eager to see how they implement these services to delight their own end users. And the best part is that these artificial intelligence services, like Amazon Personalize, do not require any machine learning experience to immediately train, tune, and deploy models to meet their business demands.”

Baidu, Inc. (NYSE:BIDU) has partnered its DuerOS Apollo Internet of Vehicles (IoV) platform with over 60 automotive manufacturers across more than 300 car models, according to an announcement from the company at the CES Asia conference in Shanghai. Zhenyu Li, Vice President and General Manager of Baidu’s Intelligent Driving Group, said:

“We are thrilled to become the trusted partner of so many leading automotive brands. We will accelerate our R&D progress, work with the industry to establish IoV standards, provide state-of-the-art IoV solutions to our automotive partners and support their evolution in the intelligent era.”

Machine Learning in Middle East and Africa 2018-2023 to See 29.1% CAGR

A report from Kenneth Research finds that the Middle East and Africa machine learning market is projected to reach a $0.5 billion USD by 2023, with a compound annual growth rate (CAGR) of 29.1 percent in the forecast period 2018-2023. An excerpt from the report description identifies key growth factors:

The labour intensive sectors like retail and healthcare have taken up the use of machine learning to provide better consumer experiences. The urge for automation in these sectors is driving the machine learning market in the Middle East and Africa.

The high growth in the start-up culture with the government encouraging innovation has led them to make ample amount of investments in machine learning technologies, which in turn is driving the machine learning market.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI  Eye

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Contact Investorideas.com

800 665 0411

  

Get more tech stocks investor ideas- news, articles, podcasts and stock directories